ArticleInternal medicine (Tokyo, Japan)2022

A Successful Case of Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab with Multisystem Immune-related Adverse Events.

Hidemi Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.